Authors: MOORE MJ TANNOCK I WINQUIST E TOLCHER A BENNETT K SEYMOUR L

Citation: Mj. Moore et al., GEMCITABINE(G)- AN ACTIVE REGIMEN IN ADVANCED CELL-CARCINOMA (TCC) - AN NCIC STUDY( CISPLATIN (C) ), Annals of oncology, 9, 1998, pp. 270-270

Authors: BJARNASON G CHARPENTIER D WINQUIST E WONG R MATTHEWS S SEYMOUR L

Citation: G. Bjarnason et al., RALTITREXED (TOMUDEX(TM)) PLUS DOXORUBICIN (DOX) IN PATIENTS WITH ADVANCED GASTRIC-CANCER - INTERIM RESULTS OF A PHASE-I DOSE-ESCALATION STUDY, Annals of oncology, 9, 1998, pp. 459-459

Authors: MOORE M TANNOCK I WINQUIST E TOLCHER A BENNETT K SEYMOUR L

Citation: M. Moore et al., GEMCITABINE (GEM) AND CISPLATIN (CIS) IS AN ACTIVE REGIMEN FOR ADVANCED TRANSITIONAL-CELL CARCINOMA (TCC) - RESULTS OF A PHASE-II STUDY, Annals of oncology, 9, 1998, pp. 646-646